Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-14
DOI
10.3389/fphar.2020.00053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
- (2019) Mitsushige Sugimoto et al. Frontiers in Pharmacology
- Helicobacter pylori Infection
- (2019) Sheila E. Crowe NEW ENGLAND JOURNAL OF MEDICINE
- Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers
- (2019) Ryohkan Funakoshi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Modulation of CYP450 activities in patients with type 2 diabetes
- (2019) Sophie Gravel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibitory Effect of Vonoprazan on the Metabolism of [14C]Prasugrel in Human Liver Microsomes
- (2019) Mitsuhiro Nishihara EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics
- (2019) Carlo A. Fallone et al. GASTROENTEROLOGY
- Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study
- (2019) Yan Xie et al. BMJ-British Medical Journal
- Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
- (2019) Paulo Roberto Xavier Tomaz et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
- (2019) Yinglian Xiao et al. GUT
- Review: Treatment of Helicobacter pylori Infection 2019
- (2019) Anthony O'Connor et al. HELICOBACTER
- A single K+-binding site in the crystal structure of the gastric proton pump
- (2019) Kenta Yamamoto et al. eLife
- Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn
- (2019) Stuart J. Spechler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency
- (2018) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Response to “CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan”
- (2018) Takuma Kagami et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan
- (2018) Mitsuhiro Nishihara et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers
- (2018) Akira Yamasaki et al. DIGESTION
- Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries
- (2018) Madelé van Dyk et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Crystal structures of the gastric proton pump
- (2018) Kazuhiro Abe et al. NATURE
- Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
- (2018) Sara R. Vazquez BLOOD
- In Vitro Assessment of Potential for CYP-Inhibition-Based Drug–Drug Interaction Between Vonoprazan and Clopidogrel
- (2018) Mitsuhiro Nishihara et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study
- (2017) Takashi Kawai et al. GUT
- Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study
- (2017) Yuji Mizokami et al. GUT
- Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats
- (2017) Osamu Yasumuro et al. XENOBIOTICA
- A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism
- (2017) Mercedes Barzi et al. Nature Communications
- Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype
- (2016) T. Kagami et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study
- (2016) Helen Jenkins et al. CLINICAL DRUG INVESTIGATION
- Prediction of CYP2D6 phenotype from genotype across world populations
- (2016) Andrea Gaedigk et al. GENETICS IN MEDICINE
- Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs
- (2016) Akifumi Kogame et al. XENOBIOTICA
- In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker
- (2016) Hitomi Yamasaki et al. XENOBIOTICA
- Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug–Drug Interactions Involving Modafinil
- (2016) Angela Rowland et al. Frontiers in Pharmacology
- Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
- (2015) H. Jenkins et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats
- (2015) Jianshe Ma et al. BIOMEDICAL CHROMATOGRAPHY
- Methadone is a local anaesthetic-like inhibitor of neuronal Na + channels and blocks excitability of mouse peripheral nerves
- (2015) C. Stoetzer et al. BRITISH JOURNAL OF ANAESTHESIA
- The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
- (2015) Hirotoshi Echizen CLINICAL PHARMACOKINETICS
- Vonoprazan: First Global Approval
- (2015) Karly P. Garnock-Jones DRUGS
- Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes
- (2014) Zhe Wang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
- (2011) Y. Hori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started